Status:
COMPLETED
Effects of an Auto-Regulating Oxygen System Compared to Constant-Flow Oxygen During Walking in Hypoxemic COPD Patients
Lead Sponsor:
Schön Klinik Berchtesgadener Land
Conditions:
COPD
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Oxygen therapy is a cornerstone in treating patients with severe chronic obstructive pulmonary disease. Usually, oxygen supplementation is delivered using constant-flow rates. Varying oxygenation leve...
Detailed Description
Rationale: Hypoxemia is frequently observed in COPD and thus can negatively impact exercise tolerance. Supplemental oxygen or long-term oxygen therapy is recommended to ensure that the patient is sti...
Eligibility Criteria
Inclusion
- GOLD III/ IV
- Hypoxemia (PaO2\<55 mmHg) under roomair conditions (rest or during exercise) or SpO2 \<88% during exercise
- established Long-term oxygen therapy or given indication for a Long-term oxygen therapy
- Age: 40 to 80 years
- Participation in an inpatient pulmonary rehabilitation program (Schoen Klinik BGL, Germany)
- Written informed consent
Exclusion
- Acute Exacerbation of COPD
- Clinical signs of any acute cardiac comorbidity
- Not able to walk
Key Trial Info
Start Date :
January 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 26 2019
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT03803384
Start Date
January 7 2019
End Date
November 26 2019
Last Update
November 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schoen Klinik Berchtesgadener Land
Schönau am Königssee, Bavaria, Germany, 83471